NO305203B1 - Oksazolidinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene for fremstilling av legemidler - Google Patents
Oksazolidinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene for fremstilling av legemidlerInfo
- Publication number
- NO305203B1 NO305203B1 NO943523A NO943523A NO305203B1 NO 305203 B1 NO305203 B1 NO 305203B1 NO 943523 A NO943523 A NO 943523A NO 943523 A NO943523 A NO 943523A NO 305203 B1 NO305203 B1 NO 305203B1
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceuticals
- compounds
- manufacture
- compound
- oxazolidinone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4332384A DE4332384A1 (de) | 1993-09-23 | 1993-09-23 | Adhäsionsrezeptor-Antagonisten III |
Publications (3)
Publication Number | Publication Date |
---|---|
NO943523D0 NO943523D0 (no) | 1994-09-22 |
NO943523L NO943523L (no) | 1995-03-24 |
NO305203B1 true NO305203B1 (no) | 1999-04-19 |
Family
ID=6498425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO943523A NO305203B1 (no) | 1993-09-23 | 1994-09-22 | Oksazolidinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene for fremstilling av legemidler |
Country Status (21)
Country | Link |
---|---|
US (3) | US5561148A (hu) |
EP (1) | EP0645376B1 (hu) |
JP (1) | JPH07179441A (hu) |
KR (1) | KR100347849B1 (hu) |
CN (1) | CN1052227C (hu) |
AT (1) | ATE178599T1 (hu) |
AU (1) | AU682050B2 (hu) |
CA (1) | CA2132579A1 (hu) |
CZ (1) | CZ288819B6 (hu) |
DE (2) | DE4332384A1 (hu) |
DK (1) | DK0645376T3 (hu) |
ES (1) | ES2132295T3 (hu) |
GR (1) | GR3030512T3 (hu) |
HU (1) | HU217980B (hu) |
NO (1) | NO305203B1 (hu) |
PL (1) | PL180462B1 (hu) |
RU (1) | RU2125560C1 (hu) |
SK (1) | SK282134B6 (hu) |
TW (1) | TW381086B (hu) |
UA (1) | UA40590C2 (hu) |
ZA (1) | ZA947405B (hu) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4313411A1 (de) * | 1993-04-23 | 1994-10-27 | Basf Ag | 3-Halogen-3-hetarylcarbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
DE4429461A1 (de) * | 1994-08-19 | 1996-02-22 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
ATE170179T1 (de) * | 1994-11-02 | 1998-09-15 | Merck Patent Gmbh | Adhäsionsrezeptor-antagonisten |
DE4439846A1 (de) * | 1994-11-08 | 1996-05-09 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
WO1996023788A1 (en) * | 1995-02-03 | 1996-08-08 | Pharmacia + Upjohn Company | Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
DE19516483A1 (de) * | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
DE19524765A1 (de) * | 1995-07-07 | 1997-01-09 | Boehringer Mannheim Gmbh | Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19601264A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
DE19601627A1 (de) * | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
DE19604223A1 (de) * | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
HRP970049A2 (en) * | 1996-02-06 | 1998-04-30 | Bayer Ag | New heteroaryl oxazolidinones |
JP2000516596A (ja) * | 1996-07-25 | 2000-12-12 | バイオジェン,インコーポレイテッド | 細胞接着インヒビター |
EP0928194A4 (en) * | 1996-08-29 | 2001-01-17 | Merck & Co Inc | COMPOSITIONS AND METHODS FOR ADMINISTERING INTEGRIN RECEPTOR ANTAGONISTS |
GB9812019D0 (en) * | 1998-06-05 | 1998-07-29 | Zeneca Ltd | Chemical compounds |
PL345162A1 (en) | 1998-06-05 | 2001-12-03 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
JP2002533416A (ja) | 1998-12-23 | 2002-10-08 | ジー.ディー.サール & カンパニー | 新形成の治療における組み合わせ治療としてのシクロオキシゲナーゼ−2インヒビターおよび一つまたはそれ以上の抗腫瘍薬の使用方法 |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
DE10159453A1 (de) * | 2001-12-04 | 2003-06-18 | Merck Patent Gmbh | Verwendung von 1-Phenyl-oxazolidin-2-on-Verbindungen als Protease |
US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
BR0308018A (pt) * | 2002-02-28 | 2005-01-04 | Astrazeneca Ab | Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo |
DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
CA2578046A1 (en) * | 2004-09-07 | 2006-03-16 | Archemix Corp. | Aptamer medicinal chemistry |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
CA2579374A1 (en) | 2004-09-07 | 2006-03-30 | Archemix Corp. | Aptamers to von willebrand factor and their use as thrombotic disease therapeutics |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
CA2624310C (en) | 2005-10-04 | 2014-01-07 | Bayer Healthcare Ag | Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
WO2008150495A2 (en) * | 2007-06-01 | 2008-12-11 | Archemix Corp. | Vwf aptamer formulations and methods for use |
EP2222636B1 (en) | 2007-12-21 | 2013-04-10 | Ligand Pharmaceuticals Inc. | Selective androgen receptor modulators (sarms) and uses thereof |
AU2009206658A1 (en) * | 2008-01-24 | 2009-07-30 | Merck Sharp & Dohme Corp. | 3,5-substituted-1,3-oxazolidin-2-one derivatives |
SG11201609050UA (en) | 2014-05-30 | 2016-12-29 | Pfizer | Carbonitrile derivatives as selective androgen receptor modulators |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791501A (fr) * | 1971-11-19 | 1973-05-17 | Albert Ag Chem Werke | Diamines cycliques n,n'-disubstituees et leur procede de preparation |
US4602093A (en) * | 1984-02-08 | 1986-07-22 | Merck & Co., Inc. | Novel substituted imidazoles, their preparation and use |
DE3723797A1 (de) * | 1987-07-18 | 1989-01-26 | Merck Patent Gmbh | Oxazolidinone |
US5053393A (en) * | 1988-07-20 | 1991-10-01 | Monsanto Company | Novel platelet-aggregation inhibitor |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
DE4005371A1 (de) * | 1990-02-21 | 1991-08-22 | Merck Patent Gmbh | Oxazolidinone |
DE4017211A1 (de) * | 1990-05-29 | 1991-12-05 | Merck Patent Gmbh | Oxazolidinone |
HU220601B1 (hu) * | 1992-04-30 | 2002-03-28 | Taiho Pharmaceutical Co. Ltd. | Fenoxi-alkil-oxazolidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények |
US5532225A (en) * | 1992-07-31 | 1996-07-02 | Sri International | Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods |
ATE181735T1 (de) * | 1993-05-01 | 1999-07-15 | Merck Patent Gmbh | Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten |
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4324393A1 (de) * | 1993-07-21 | 1995-01-26 | Merck Patent Gmbh | 4-Aryloxy- und 4-Arylthiopiperidinderivate |
DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
TW286317B (hu) * | 1993-12-13 | 1996-09-21 | Hoffmann La Roche | |
TW363051B (en) * | 1995-08-31 | 1999-07-01 | Mitsui Toatsu Chemicals | Substituted amidine derivatives and platelet aggregation inhibitor containing the same |
-
1993
- 1993-09-23 DE DE4332384A patent/DE4332384A1/de not_active Withdrawn
-
1994
- 1994-08-01 UA UA94085682A patent/UA40590C2/uk unknown
- 1994-09-14 CZ CZ19942247A patent/CZ288819B6/cs not_active IP Right Cessation
- 1994-09-15 DE DE59408068T patent/DE59408068D1/de not_active Expired - Fee Related
- 1994-09-15 ES ES94114519T patent/ES2132295T3/es not_active Expired - Lifetime
- 1994-09-15 AT AT94114519T patent/ATE178599T1/de not_active IP Right Cessation
- 1994-09-15 EP EP94114519A patent/EP0645376B1/de not_active Expired - Lifetime
- 1994-09-15 DK DK94114519T patent/DK0645376T3/da active
- 1994-09-16 AU AU73050/94A patent/AU682050B2/en not_active Ceased
- 1994-09-19 SK SK1121-94A patent/SK282134B6/sk unknown
- 1994-09-20 CN CN94115356A patent/CN1052227C/zh not_active Expired - Fee Related
- 1994-09-20 JP JP6224941A patent/JPH07179441A/ja not_active Withdrawn
- 1994-09-21 CA CA002132579A patent/CA2132579A1/en not_active Abandoned
- 1994-09-21 TW TW083108683A patent/TW381086B/zh not_active IP Right Cessation
- 1994-09-22 PL PL94305144A patent/PL180462B1/pl unknown
- 1994-09-22 KR KR1019940023840A patent/KR100347849B1/ko not_active IP Right Cessation
- 1994-09-22 ZA ZA947405A patent/ZA947405B/xx unknown
- 1994-09-22 NO NO943523A patent/NO305203B1/no not_active IP Right Cessation
- 1994-09-22 HU HU9402724A patent/HU217980B/hu not_active IP Right Cessation
- 1994-09-22 US US08/310,085 patent/US5561148A/en not_active Expired - Fee Related
- 1994-09-23 RU RU94034124A patent/RU2125560C1/ru not_active IP Right Cessation
-
1996
- 1996-05-29 US US08/654,690 patent/US5723480A/en not_active Expired - Fee Related
-
1997
- 1997-11-06 US US08/964,131 patent/US6028090A/en not_active Expired - Fee Related
-
1999
- 1999-06-15 GR GR990401587T patent/GR3030512T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5561148A (en) | 1996-10-01 |
JPH07179441A (ja) | 1995-07-18 |
CZ288819B6 (cs) | 2001-09-12 |
AU682050B2 (en) | 1997-09-18 |
AU7305094A (en) | 1995-04-06 |
HU9402724D0 (en) | 1994-12-28 |
US6028090A (en) | 2000-02-22 |
ATE178599T1 (de) | 1999-04-15 |
NO943523L (no) | 1995-03-24 |
KR950008493A (ko) | 1995-04-17 |
CN1106806A (zh) | 1995-08-16 |
SK282134B6 (sk) | 2001-11-06 |
TW381086B (en) | 2000-02-01 |
US5723480A (en) | 1998-03-03 |
HU217980B (hu) | 2000-05-28 |
RU94034124A (ru) | 1996-07-10 |
RU2125560C1 (ru) | 1999-01-27 |
DE4332384A1 (de) | 1995-03-30 |
ES2132295T3 (es) | 1999-08-16 |
CA2132579A1 (en) | 1995-03-24 |
NO943523D0 (no) | 1994-09-22 |
ZA947405B (en) | 1995-05-15 |
DE59408068D1 (de) | 1999-05-12 |
PL180462B1 (pl) | 2001-02-28 |
HUT71233A (en) | 1995-11-28 |
SK112194A3 (en) | 1995-05-10 |
EP0645376B1 (de) | 1999-04-07 |
KR100347849B1 (ko) | 2002-11-16 |
PL305144A1 (en) | 1995-04-03 |
UA40590C2 (uk) | 2001-08-15 |
CN1052227C (zh) | 2000-05-10 |
DK0645376T3 (da) | 1999-10-18 |
EP0645376A1 (de) | 1995-03-29 |
GR3030512T3 (en) | 1999-10-29 |
CZ224794A3 (en) | 1995-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO305203B1 (no) | Oksazolidinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene for fremstilling av legemidler | |
NO301419B1 (no) | 2-okso-5-oksazolidinmetylforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse derav for fremstilling av legemidler | |
YU155290A (sh) | Dusikove spojine | |
EP0632031A4 (hu) | ||
BR9503536A (pt) | Composto processo para sua preparação seu uso e composição farmacêutica | |
NO302519B1 (no) | Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat | |
NO178660C (no) | Analogifremgangsmåte for fremstilling av N-aryl-piperazinalkanamidforbindelser | |
DK14389A (da) | Substituerede 3-aminosydnoniminer og farmakologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter ved fremstillingen | |
ATE69605T1 (de) | Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide. | |
DE3377647D1 (de) | 5-halovinyl-2'-deoxyuridine derivatives | |
SE8201098L (sv) | Nya ergolinderivat, deras framstellning och farmaceutiska kompositioner derav | |
ES2058458T3 (es) | Inhibidor de la formacion de la placa dental. | |
DK20886D0 (da) | Imidazolderivater, deres fremstilling og terapeutiske anvendelse | |
NO842003L (no) | Substituerte isokinolinderivater | |
DK143991D0 (da) | Syreadditionssalte af optisk aktive alaninanilidforbindelser og farmaceutiske praeparater indeholdende disse | |
MY101628A (en) | Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them. | |
EP0309262A3 (en) | Novel salicylates, their salts, pharmaceutical compositions containing them and process for preparing same | |
GB1527941A (en) | 1-(3-phenylpropyl)-4-(beta-alkoxyacryloyl)piperazine derivatives | |
SE8100122L (sv) | Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa | |
ATE101119T1 (de) | Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung. | |
FR2396739A1 (fr) | 1-aminomethyltricyclo(4.3.1.12,5)undecane et ses sels d'addition d'acide | |
DE69011174D1 (de) | Catecholaminester. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |